ZNTL Stock Analysis: Buy, Sell, or Hold?
ZNTL - Zentalis Pharmaceuticals, Inc. Common Stock
$2.43
-0.08 (-3.19%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 04, 2026
Get Alerted When ZNTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ZNTL is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ZNTL is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZNTL is currently trading at $2.43, which is considered slightly high relative to its 30-day fair value range of $1.40 to $3.18.
Technical Outlook: Technically, ZNTL is in a uptrend. The price is currently testing key support at $2.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.31 (+111.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZNTL is in a uptrend. The price is currently testing key support at $2.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.31 (+111.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.40 -
$3.18
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
Protect Your Profits
Holding ZNTL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 111.7% below Wall St target ($5.31)
- WARNING: Recommendation downgraded due to -17.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.40 -
$3.18
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.44
Resistance Level
$3.29
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.38
Wall Street Target
$5.31
(+111.7%)
Last updated: January 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZNTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
Advanced ZNTL Option Strategies
Professional options setups generated by AI based on today's ZNTL price and gamma walls.
